Copyright Reports & Markets. All rights reserved.

Global Ceritinib API Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Ceritinib API Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Purity≥99%
    • 1.3.3 Purity<99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Ceritinib API Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Online Sales
    • 1.4.3 Offline Sales
  • 1.5 Global Ceritinib API Market Size & Forecast
    • 1.5.1 Global Ceritinib API Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Ceritinib API Sales Quantity (2021-2032)
    • 1.5.3 Global Ceritinib API Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 MSN Laboratories
    • 2.1.1 MSN Laboratories Details
    • 2.1.2 MSN Laboratories Major Business
    • 2.1.3 MSN Laboratories Ceritinib API Product and Services
    • 2.1.4 MSN Laboratories Ceritinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 MSN Laboratories Recent Developments/Updates
  • 2.2 SP Accure Labs
    • 2.2.1 SP Accure Labs Details
    • 2.2.2 SP Accure Labs Major Business
    • 2.2.3 SP Accure Labs Ceritinib API Product and Services
    • 2.2.4 SP Accure Labs Ceritinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 SP Accure Labs Recent Developments/Updates
  • 2.3 Clearsynth Labs
    • 2.3.1 Clearsynth Labs Details
    • 2.3.2 Clearsynth Labs Major Business
    • 2.3.3 Clearsynth Labs Ceritinib API Product and Services
    • 2.3.4 Clearsynth Labs Ceritinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Clearsynth Labs Recent Developments/Updates
  • 2.4 Dr. Reddys Laboratories
    • 2.4.1 Dr. Reddys Laboratories Details
    • 2.4.2 Dr. Reddys Laboratories Major Business
    • 2.4.3 Dr. Reddys Laboratories Ceritinib API Product and Services
    • 2.4.4 Dr. Reddys Laboratories Ceritinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Dr. Reddys Laboratories Recent Developments/Updates
  • 2.5 Selleck Chemicals
    • 2.5.1 Selleck Chemicals Details
    • 2.5.2 Selleck Chemicals Major Business
    • 2.5.3 Selleck Chemicals Ceritinib API Product and Services
    • 2.5.4 Selleck Chemicals Ceritinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Selleck Chemicals Recent Developments/Updates
  • 2.6 LC Laboratories
    • 2.6.1 LC Laboratories Details
    • 2.6.2 LC Laboratories Major Business
    • 2.6.3 LC Laboratories Ceritinib API Product and Services
    • 2.6.4 LC Laboratories Ceritinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 LC Laboratories Recent Developments/Updates
  • 2.7 Bio-Techne
    • 2.7.1 Bio-Techne Details
    • 2.7.2 Bio-Techne Major Business
    • 2.7.3 Bio-Techne Ceritinib API Product and Services
    • 2.7.4 Bio-Techne Ceritinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Bio-Techne Recent Developments/Updates
  • 2.8 Enzo Biochem
    • 2.8.1 Enzo Biochem Details
    • 2.8.2 Enzo Biochem Major Business
    • 2.8.3 Enzo Biochem Ceritinib API Product and Services
    • 2.8.4 Enzo Biochem Ceritinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Enzo Biochem Recent Developments/Updates
  • 2.9 Cayman Chemical
    • 2.9.1 Cayman Chemical Details
    • 2.9.2 Cayman Chemical Major Business
    • 2.9.3 Cayman Chemical Ceritinib API Product and Services
    • 2.9.4 Cayman Chemical Ceritinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Cayman Chemical Recent Developments/Updates
  • 2.10 Anhui Menovo Pharmaceutical
    • 2.10.1 Anhui Menovo Pharmaceutical Details
    • 2.10.2 Anhui Menovo Pharmaceutical Major Business
    • 2.10.3 Anhui Menovo Pharmaceutical Ceritinib API Product and Services
    • 2.10.4 Anhui Menovo Pharmaceutical Ceritinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Anhui Menovo Pharmaceutical Recent Developments/Updates
  • 2.11 Nanjing Hairun Medicine
    • 2.11.1 Nanjing Hairun Medicine Details
    • 2.11.2 Nanjing Hairun Medicine Major Business
    • 2.11.3 Nanjing Hairun Medicine Ceritinib API Product and Services
    • 2.11.4 Nanjing Hairun Medicine Ceritinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Nanjing Hairun Medicine Recent Developments/Updates
  • 2.12 Nanjing Wedo Pharmatech
    • 2.12.1 Nanjing Wedo Pharmatech Details
    • 2.12.2 Nanjing Wedo Pharmatech Major Business
    • 2.12.3 Nanjing Wedo Pharmatech Ceritinib API Product and Services
    • 2.12.4 Nanjing Wedo Pharmatech Ceritinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Nanjing Wedo Pharmatech Recent Developments/Updates

3 Competitive Environment: Ceritinib API by Manufacturer

  • 3.1 Global Ceritinib API Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Ceritinib API Revenue by Manufacturer (2021-2026)
  • 3.3 Global Ceritinib API Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Ceritinib API by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Ceritinib API Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Ceritinib API Manufacturer Market Share in 2025
  • 3.5 Ceritinib API Market: Overall Company Footprint Analysis
    • 3.5.1 Ceritinib API Market: Region Footprint
    • 3.5.2 Ceritinib API Market: Company Product Type Footprint
    • 3.5.3 Ceritinib API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Ceritinib API Market Size by Region
    • 4.1.1 Global Ceritinib API Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Ceritinib API Consumption Value by Region (2021-2032)
    • 4.1.3 Global Ceritinib API Average Price by Region (2021-2032)
  • 4.2 North America Ceritinib API Consumption Value (2021-2032)
  • 4.3 Europe Ceritinib API Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Ceritinib API Consumption Value (2021-2032)
  • 4.5 South America Ceritinib API Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Ceritinib API Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Ceritinib API Sales Quantity by Type (2021-2032)
  • 5.2 Global Ceritinib API Consumption Value by Type (2021-2032)
  • 5.3 Global Ceritinib API Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Ceritinib API Sales Quantity by Application (2021-2032)
  • 6.2 Global Ceritinib API Consumption Value by Application (2021-2032)
  • 6.3 Global Ceritinib API Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Ceritinib API Sales Quantity by Type (2021-2032)
  • 7.2 North America Ceritinib API Sales Quantity by Application (2021-2032)
  • 7.3 North America Ceritinib API Market Size by Country
    • 7.3.1 North America Ceritinib API Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Ceritinib API Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Ceritinib API Sales Quantity by Type (2021-2032)
  • 8.2 Europe Ceritinib API Sales Quantity by Application (2021-2032)
  • 8.3 Europe Ceritinib API Market Size by Country
    • 8.3.1 Europe Ceritinib API Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Ceritinib API Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Ceritinib API Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Ceritinib API Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Ceritinib API Market Size by Region
    • 9.3.1 Asia-Pacific Ceritinib API Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Ceritinib API Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Ceritinib API Sales Quantity by Type (2021-2032)
  • 10.2 South America Ceritinib API Sales Quantity by Application (2021-2032)
  • 10.3 South America Ceritinib API Market Size by Country
    • 10.3.1 South America Ceritinib API Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Ceritinib API Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Ceritinib API Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Ceritinib API Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Ceritinib API Market Size by Country
    • 11.3.1 Middle East & Africa Ceritinib API Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Ceritinib API Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Ceritinib API Market Drivers
  • 12.2 Ceritinib API Market Restraints
  • 12.3 Ceritinib API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Ceritinib API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Ceritinib API
  • 13.3 Ceritinib API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Ceritinib API Typical Distributors
  • 14.3 Ceritinib API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Ceritinib API market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Ceritinib is an active pharmaceutical ingredient (API) used as a targeted therapy for treating non-small cell lung cancer (NSCLC) with ALK gene rearrangements.It functions as a potent and selective ALK inhibitor,blocking the activity of the ALK protein,which is implicated in the growth and survival of cancer cells.
    This report is a detailed and comprehensive analysis for global Ceritinib API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Ceritinib API market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
    Global Ceritinib API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
    Global Ceritinib API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
    Global Ceritinib API market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/kg), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Ceritinib API
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Ceritinib API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MSN Laboratories, SP Accure Labs, Clearsynth Labs, Dr. Reddys Laboratories, Selleck Chemicals, LC Laboratories, Bio-Techne, Enzo Biochem, Cayman Chemical, Anhui Menovo Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Ceritinib API market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Purity≥99%
    Purity<99%
    Market segment by Application
    Online Sales
    Offline Sales
    Major players covered
    MSN Laboratories
    SP Accure Labs
    Clearsynth Labs
    Dr. Reddys Laboratories
    Selleck Chemicals
    LC Laboratories
    Bio-Techne
    Enzo Biochem
    Cayman Chemical
    Anhui Menovo Pharmaceutical
    Nanjing Hairun Medicine
    Nanjing Wedo Pharmatech
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Ceritinib API product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Ceritinib API, with price, sales quantity, revenue, and global market share of Ceritinib API from 2021 to 2026.
    Chapter 3, the Ceritinib API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Ceritinib API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Ceritinib API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Ceritinib API.
    Chapter 14 and 15, to describe Ceritinib API sales channel, distributors, customers, research findings and conclusion.

    Buy now